dinutuximab beta

Italy

Drugs containing this active substance

  • QARZIBA

    It is used for the treatment of neuroblastoma (a type of cancer that affects nerve cells) in patients at high risk of relapse after other treatments, or in cases of neuroblastoma that has recurred or has not been completely cured by previous therapies. It is indicated for patients from 12 months of age.

    Form: solution for infusion, concentrate

    Active substance Dosage
    dinutuximab beta -

    ATC: L01FX06

    Manufacturer: RECORDATI NETHERLANDS B.V.